iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
186.41
-3.55 (-1.87%)
At close: Jul 31, 2026, 4:00 PM EDT
186.50
+0.09 (0.05%)
After-hours: Jul 31, 2026, 7:46 PM EDT
IBB Holdings Information
IBB is an equity ETF with a total of 252 individual holdings. The top holdings are Amgen stock at 8.42%, Vertex Pharmaceuticals at 7.87%, Gilead Sciences at 7.14%, Regeneron Pharmaceuticals at 5.84%, and argenx SE at 3.55%.
Total Holdings
252
Top 10 Percentage
45.52%
Asset Class
Equity
ETF Category
Health
Assets
9.21B
PE Ratio
23.20
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 8.42% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.87% |
| 3 | GILD | Gilead Sciences, Inc. | 7.14% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.84% |
| 5 | ARGX | argenx SE | 3.55% |
| 6 | NTRA | Natera, Inc. | 2.88% |
| 7 | RVMD | Revolution Medicines, Inc. | 2.87% |
| 8 | ILMN | Illumina, Inc. | 2.42% |
| 9 | BIIB | Biogen Inc. | 2.38% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.14% |
| 11 | ONC | BeOne Medicines AG | 2.01% |
| 12 | INCY | Incyte Corporation | 1.91% |
| 13 | INSM | Insmed Incorporated | 1.71% |
| 14 | UTHR | United Therapeutics Corporation | 1.69% |
| 15 | MRNA | Moderna, Inc. | 1.65% |
| 16 | NBIX | Neurocrine Biosciences, Inc. | 1.44% |
| 17 | ROIV | Roivant Sciences Ltd. | 1.40% |
| 18 | ASND | Ascendis Pharma A/S | 1.22% |
| 19 | GMAB | Genmab A/S | 1.17% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.09% |
| 21 | EXEL | Exelixis, Inc. | 1.07% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.04% |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.91% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 0.90% |
| 25 | TECH | Bio-Techne Corporation | 0.88% |
As of Jul 30, 2026